We aimed to investigate cardiovascular disease (CVD) risk and risk factors and evaluate the relationship among disease activity, inflammation markers, and uric acid levels in patients with rheumatoid arthritis (RA) and spondyloarthritis (SpA). Materials and Methods: In this study, 98 patients with RA, 41 patients with SpA, and 95 controls were included. Participants' demographic features, levels of body mass index (BMI), blood pressure (BP), waist circumference, glucose, cholesterol, uric acid, disease activity, and metabolic syndrome (MetS) prevalence were recorded. The 10-year CVD risk and heart age were calculated by using the Framingham risk score. Results: The mean BMI, systolic BP, diastolic BP, and waist circumference were higher in RA patients. There was no difference among patients with RA, those with SpA, and controls in terms of MetS prevalence (43.9%, 41.5%, and 35.8%, respectively, p=0.510) and 10-year CVD risk (12.7±10.2, 9.2±8.7, and 11.4±10.8, respectively, p=0.174). Higher uric acid levels were indicated in patients with MetS in both RA and SpA groups. Uric acid levels were associated with the Framingham score in RA patients. Conclusion: In patients with RA and SpA, CVD risk was determined to be similar to that of the general population. On the other hand, the uric acid level was found to be correlated with the risk of MetS, and uric acid is associated with CVD risk, especially in patients with RA.
BackgroundPain remains the most important challenge for rheumatoid arthritis (RA) patients. In order to cope with pain in RA, clinicians firstly need to understand the degree of patients’pain. When self reported measures such as visual analog scale were used, inconsistency between clinicians’ and patients’ ratings of pain was demonstrated (1). As a result, inability to fully assess the pain will cause the inability to fully assess the impact of pain on disease severity. Measuring pressure pain threshold with pressure algometry may provide additional advantages for the evaluation of pain and disease severity when compared with self-reported measures.ObjectivesThe aim of this study was to evaluate the pain threshold and to determine the variables associated with pain threshold in the patients with RA.MethodsThe current study included 100 RA patients and 80 age-sex matched controls with non-inflammatory chronic low back pain. Clinical parameters, functional status, disease activity, pain, fatigue, depression, anxiety, pain catastrophizing and laboratory activity of RA patients were recorded. The pressure pain thresholds on the dominant thumb nail bed, trapezius and wrist of the two groups were measured by the algometer. The pain thresholds of the paients with RA and controls were compared. Moreover, the relation between pain threholds and all evaluated parameters in RA patients was analysed.ResultsThe mean age of RA patients was 55.93 ± 10.81; the mean age of the controls was54,50 ± 9,47. The pain thresholds of RA patients and controls were statistically similar in all areas. When the parameters found to be significantly correlated with pain threshold in RA patients were analyzed by regression analysis, depression was the only factor associated with low pain threshold in all areas (Table 1).ConclusionWe found that depression was the only factor associated with low pain threshold in the patients with RA. The use of pressure algometry in the evaluation of chronic pain could offer an additional method to detect pain/depression overlap.Table 1 The correlation between pain threshold values and demographic, clinical and laboratory parameters of RA patients Nail PT Wrist PT Trapezius PT prprpr Age 0,5510,0600,7050,0380,8060,025 BMI (kg/m2) 0,174-0,1370,066-0,1850,046*-0,200 Duration of disease (year) 0,247-0,1170,144-0,1470,3640,092 Morning stiffness (minute) 0,415-0,0820,592-0,0540,542-0,062 Tender joint counts 0,046*-0,2000,099-0,1660,361-0,092 Swollen joint counts 0,109-0,1610,227-0,1220,522-0,065 CRP 0,681-0,0420,1440,1470,0760,178 ESR 0,952-0,0060,3300,0980,4530,076 VAS 0,056-0,1920,069-0,1820,086-0,173 PCS 0,013*-0,2480,013*-0,2490,034*-0,212 Fatigue Intensity Scale 0,107-0,1620,145-0,1470,422-0,081 HADS-Anxiety 0,157-0,1430,118-0,1570,285-0,108 HADS-Depression 0,010*-0,2560,005*-0,2820,003*-0,293 HADS-Total 0,026*-0,2230,014*-0,2450,024*-0,225 HAQ <0,001*-0,2640,000*-0,287<0,001*-0,315 DAS28-ESR 0,013*-0,2480,091-0,1700,211-0,126 DAS28-CRP 0,009*-0,2610,066-0,1850,220-0,124PT: pain threshold, BMI: Body mass index, ...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.